Open AccessSafety of rifabutin replacing rifampicin in the treatment of tuberculosis: a single-centre retrospective cohort study
Author(s) -
JungYien Chien,
Shun-Tien Chien,
Shasha Huang,
ChongJen Yu
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt446
Subject(s) - rifabutin , rifampicin , medicine , tuberculosis , adverse effect , antibacterial agent , retrospective cohort study , cohort study , cohort , antibiotics , surgery , microbiology and biotechnology , pathology , clarithromycin , biology , helicobacter pylori
The safety of rifabutin replacing rifampicin among adults having rifampicin-related adverse reactions (ARs) during the treatment of tuberculosis remains unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom